
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $185.9M | $248.4M | $316.4M | $380.7M | $438.9M | |
Revenue Growth (YoY) | 24.3% | 33.61% | 27.35% | 20.35% | 15.29% | |
Cost of Revenues | $83.8M | $100.1M | $117.9M | $121.3M | $121.8M | |
Gross Profit | $102.2M | $148.3M | $198.5M | $259.4M | $317.2M | |
Gross Profit Margin | 54.95% | 59.71% | 62.74% | 68.14% | 72.26% | |
R&D Expenses | $44.5M | $65.1M | $83.9M | $97.6M | $101.1M | |
Selling, General & Admin | $104.3M | $159.8M | $169.1M | $179.4M | $182.1M | |
Other Inc / (Exp) | -$8.5M | -$77.5M | -- | -- | -$286K | |
Operating Expenses | $176.3M | $255.6M | $285.9M | $312.9M | $319.4M | |
Operating Income | -$74.1M | -$107.3M | -$87.4M | -$53.5M | -$2.3M | |
Net Interest Expenses | $18.4M | $19.4M | $13.6M | -- | -- | |
EBT. Incl. Unusual Items | -$101M | -$204.3M | -$101M | -$46.1M | $9.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $234K | -$4.7M | $321K | $1.2M | $921K | |
Net Income to Company | -$101.2M | -$199.6M | -$101.3M | -$47.3M | $8.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$101.2M | -$199.6M | -$101.3M | -$47.3M | $8.1M | |
Basic EPS (Cont. Ops) | -$0.99 | -$2.64 | -$0.51 | -$0.23 | $0.04 | |
Diluted EPS (Cont. Ops) | -$0.99 | -$2.64 | -$0.51 | -$0.23 | $0.04 | |
Weighted Average Basic Share | $168.1M | $85.1M | $198M | $201.9M | $206.1M | |
Weighted Average Diluted Share | $168.1M | $85.1M | $198M | $201.9M | $209.2M | |
EBITDA | -$53.4M | -$153.5M | -$47.4M | $3.3M | $56.7M | |
EBIT | -$80.9M | -$184.2M | -$80.2M | -$32.6M | $20.4M | |
Revenue (Reported) | $185.9M | $248.4M | $316.4M | $380.7M | $438.9M | |
Operating Income (Reported) | -$74.1M | -$107.3M | -$87.4M | -$53.5M | -$2.3M | |
Operating Income (Adjusted) | -$80.9M | -$184.2M | -$80.2M | -$32.6M | $20.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $55.2M | $71.2M | $86.8M | $105.6M | $107.9M | |
Revenue Growth (YoY) | -- | 28.96% | 21.94% | 21.63% | 2.22% | |
Cost of Revenues | $22.5M | $27.8M | $29.5M | $30.3M | $30.8M | |
Gross Profit | $32.7M | $43.4M | $57.3M | $75.3M | $77.2M | |
Gross Profit Margin | 59.18% | 60.95% | 66.05% | 71.28% | 71.48% | |
R&D Expenses | $13.9M | $20.1M | $23.1M | $25.9M | $25.4M | |
Selling, General & Admin | $27.7M | $35.9M | $42.8M | $44M | $51.5M | |
Other Inc / (Exp) | -$49.1M | -- | -- | -$162K | -- | |
Operating Expenses | $48.7M | $63.7M | $74.5M | $79.2M | $85.5M | |
Operating Income | -$16M | -$20.3M | -$17.1M | -$3.9M | -$8.4M | |
Net Interest Expenses | $4.9M | $4.8M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$70M | -$25.1M | -$15.9M | -$884K | -$6.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $68K | $69K | $70K | $125K | $1.1M | |
Net Income to Company | -$70M | -$25.1M | -$16M | -$1M | -$7.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$70M | -$25.1M | -$16M | -$1M | -$7.3M | |
Basic EPS (Cont. Ops) | -$0.44 | -$0.13 | -$0.08 | -- | -$0.04 | |
Diluted EPS (Cont. Ops) | -$0.44 | -$0.13 | -$0.08 | -- | -$0.04 | |
Weighted Average Basic Share | $168.1M | $197M | $199.9M | $204.9M | $205M | |
Weighted Average Diluted Share | $168.1M | $197M | $199.9M | $204.9M | $205M | |
EBITDA | -$57.9M | -$12.4M | -$4M | $11.8M | $4.5M | |
EBIT | -$64.9M | -$20.1M | -$12.6M | $2.5M | -$4.2M | |
Revenue (Reported) | $55.2M | $71.2M | $86.8M | $105.6M | $107.9M | |
Operating Income (Reported) | -$16M | -$20.3M | -$17.1M | -$3.9M | -$8.4M | |
Operating Income (Adjusted) | -$64.9M | -$20.1M | -$12.6M | $2.5M | -$4.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $264.4M | $332M | $399.5M | $441.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $105.4M | $119.5M | $122.2M | $122.2M | |
Gross Profit | -- | $159M | $212.4M | $277.3M | $319M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $71.3M | $87M | $100.3M | $100.6M | |
Selling, General & Admin | -- | $168M | $176M | $180.7M | $189.5M | |
Other Inc / (Exp) | -$50M | -$28.5M | -- | -$162K | -$124K | |
Operating Expenses | -- | $270.7M | $296.6M | $317.7M | $325.7M | |
Operating Income | -- | -$111.6M | -$84.2M | -$40.3M | -$6.7M | |
Net Interest Expenses | $14.3M | $19.3M | $7.6M | -- | -- | |
EBT. Incl. Unusual Items | -- | -$159.4M | -$91.8M | -$31.1M | $3.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -$4.7M | $322K | $1.3M | $1.9M | |
Net Income to Company | -- | -$154.8M | -$92.1M | -$32.3M | $1.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$154.8M | -$92.1M | -$32.3M | $1.8M | |
Basic EPS (Cont. Ops) | -- | -$0.95 | -$0.47 | -$0.15 | $0.00 | |
Diluted EPS (Cont. Ops) | -- | -$0.95 | -$0.47 | -$0.15 | $0.00 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$108M | -$39M | $19.1M | $49.4M | |
EBIT | -- | -$139.4M | -$72.7M | -$17.6M | $13.7M | |
Revenue (Reported) | -- | $264.4M | $332M | $399.5M | $441.3M | |
Operating Income (Reported) | -- | -$111.6M | -$84.2M | -$40.3M | -$6.7M | |
Operating Income (Adjusted) | -- | -$139.4M | -$72.7M | -$17.6M | $13.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $55.2M | $71.2M | $86.8M | $105.6M | $107.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $22.5M | $27.8M | $29.5M | $30.3M | $30.8M | |
Gross Profit | $32.7M | $43.4M | $57.3M | $75.3M | $77.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $13.9M | $20.1M | $23.1M | $25.9M | $25.4M | |
Selling, General & Admin | $27.7M | $35.9M | $42.8M | $44M | $51.5M | |
Other Inc / (Exp) | -$49.1M | -- | -- | -$162K | -- | |
Operating Expenses | $48.7M | $63.7M | $74.5M | $79.2M | $85.5M | |
Operating Income | -$16M | -$20.3M | -$17.1M | -$3.9M | -$8.4M | |
Net Interest Expenses | $4.9M | $4.8M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$70M | -$25.1M | -$15.9M | -$884K | -$6.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $68K | $69K | $70K | $125K | $1.1M | |
Net Income to Company | -$70M | -$25.1M | -$16M | -$1M | -$7.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$70M | -$25.1M | -$16M | -$1M | -$7.3M | |
Basic EPS (Cont. Ops) | -$0.44 | -$0.13 | -$0.08 | -- | -$0.04 | |
Diluted EPS (Cont. Ops) | -$0.44 | -$0.13 | -$0.08 | -- | -$0.04 | |
Weighted Average Basic Share | $168.1M | $197M | $199.9M | $204.9M | $205M | |
Weighted Average Diluted Share | $168.1M | $197M | $199.9M | $204.9M | $205M | |
EBITDA | -$57.9M | -$12.4M | -$4M | $11.8M | $4.5M | |
EBIT | -$64.9M | -$20.1M | -$12.6M | $2.5M | -$4.2M | |
Revenue (Reported) | $55.2M | $71.2M | $86.8M | $105.6M | $107.9M | |
Operating Income (Reported) | -$16M | -$20.3M | -$17.1M | -$3.9M | -$8.4M | |
Operating Income (Adjusted) | -$64.9M | -$20.1M | -$12.6M | $2.5M | -$4.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $252.5M | $562.8M | $350.6M | $407M | $355.6M | |
Short Term Investments | -- | -- | $111M | $44.6M | $33.7M | |
Accounts Receivable, Net | $24.8M | $31M | $39.7M | $46.7M | $51.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $8.6M | $10.2M | $12.6M | $12.1M | $15.3M | |
Total Current Assets | $432.3M | $1.9B | $1.8B | $2.1B | $1.7B | |
Property Plant And Equipment | $90M | $109.5M | $106.2M | $102.6M | $97.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $105.7M | $165.9M | $165.9M | $165.9M | $165.9M | |
Other Intangibles | $72.4M | $100.5M | $98.7M | $84.8M | $71.1M | |
Other Long-Term Assets | $1.9M | $4.3M | $5.2M | $4M | $6.3M | |
Total Assets | $726.5M | $2.3B | $2.2B | $2.5B | $2.1B | |
Accounts Payable | $25.4M | $17.1M | $13.5M | $16.8M | $15.5M | |
Accrued Expenses | $40.5M | $56.1M | $73.5M | $56.4M | $46.8M | |
Current Portion Of Long-Term Debt | $1M | $4.8M | $6.4M | $6.4M | $4.8M | |
Current Portion Of Capital Lease Obligations | $2.2M | $1.7M | $1.9M | $1.8M | $1.3M | |
Other Current Liabilities | $137.6M | $1.2B | $1.3B | $1.6B | $1.3B | |
Total Current Liabilities | $213.1M | $1.3B | $1.4B | $1.7B | $1.3B | |
Long-Term Debt | $98.4M | $119.9M | $75.9M | $69.8M | $4.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.5B | $1.6B | $1.8B | $1.4B | |
Common Stock | $50K | $197K | $199K | $204K | $204K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$511.1M | $723.1M | $657.4M | $656.4M | $671.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$511.1M | $723.1M | $657.4M | $656.4M | $671.8M | |
Total Liabilities and Equity | $726.5M | $2.3B | $2.2B | $2.5B | $2.1B | |
Cash and Short Terms | $252.5M | $562.8M | $461.5M | $451.6M | $389.3M | |
Total Debt | $99.4M | $124.7M | $82.3M | $76.2M | $9.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $294.9M | $368.2M | $343.7M | $307.3M | |
Short Term Investments | -- | $228.7M | $63.5M | $99.9M | $82M | |
Accounts Receivable, Net | -- | $34.2M | $43.1M | $48.9M | $53.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $13.8M | $15.1M | $15.3M | $17.4M | |
Total Current Assets | -- | $1.5B | $1.6B | $1.7B | $1.6B | |
Property Plant And Equipment | -- | $111.5M | $105.3M | $101.7M | $97.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $165.9M | $165.9M | $165.9M | $165.9M | |
Other Intangibles | -- | $106M | $95.4M | $80.9M | $68M | |
Other Long-Term Assets | -- | $4.3M | $4.4M | $4.6M | $6.8M | |
Total Assets | -- | $1.9B | $2B | $2.1B | $2B | |
Accounts Payable | -- | $15.5M | $13.3M | $15.4M | $19.5M | |
Accrued Expenses | -- | $51.5M | $52.1M | $39.6M | $38.5M | |
Current Portion Of Long-Term Debt | -- | $4.8M | $6.4M | $6.4M | $4.8M | |
Current Portion Of Capital Lease Obligations | -- | $1.8M | $2M | $1.9M | $1.1M | |
Other Current Liabilities | -- | $932.7M | $1.1B | $1.2B | $1.1B | |
Total Current Liabilities | -- | $1B | $1.1B | $1.3B | $1.2B | |
Long-Term Debt | -- | $121.4M | $75.6M | $69.4M | $4.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $1.2B | $1.3B | $1.4B | $1.3B | |
Common Stock | -- | $198K | $201K | $206K | $206K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $704.9M | $650.8M | $669.6M | $679.2M | |
Total Liabilities and Equity | -- | $1.9B | $2B | $2.1B | $2B | |
Cash and Short Terms | -- | $523.6M | $431.7M | $443.5M | $389.3M | |
Total Debt | -- | $126.2M | $82M | $75.8M | $9.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$101.2M | -$199.6M | -$101.3M | -$47.3M | $8.1M | |
Depreciation & Amoritzation | $27.5M | $30.7M | $32.8M | $35.9M | $36.3M | |
Stock-Based Compensation | $1.6M | $21.4M | $31.8M | $40.9M | $47.2M | |
Change in Accounts Receivable | -$5.7M | -$4.7M | -$10.3M | -$8.3M | -$6.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$44.1M | -$68.7M | -$28.7M | $8.5M | $71.9M | |
Capital Expenditures | $12M | $18.3M | $27.8M | $18.3M | $19.6M | |
Cash Acquisitions | -$19.8M | -$47.4M | -- | -- | -- | |
Cash From Investing | -$36.6M | -$84.1M | -$140.3M | $51.9M | -$11.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.5M | $3.5M | $67.4M | -- | -- | |
Long-Term Debt Repaid | -$2.6M | -$2.1M | -$112M | -$6.9M | -$68.5M | |
Repurchase of Common Stock | -$195.7M | -$169M | -- | -- | -$50.1M | |
Other Financing Activities | $65.4M | $1.1B | $39.9M | $294M | -$329.9M | |
Cash From Financing | $193.8M | $1.6B | -$1.7M | $290.8M | -$440.3M | |
Beginning Cash (CF) | $277M | $390.1M | $1.8B | $1.6B | $2B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $113.1M | $1.4B | -$170.8M | $351.2M | -$379.6M | |
Ending Cash (CF) | $390.1M | $1.8B | $1.6B | $2B | $1.6B | |
Levered Free Cash Flow | -$56.2M | -$87M | -$56.5M | -$9.9M | $52.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$70M | -$25.1M | -$16M | -$1M | -$7.3M | |
Depreciation & Amoritzation | $7.1M | $7.7M | $8.6M | $9.3M | $8.7M | |
Stock-Based Compensation | $847K | $6.8M | $8.9M | $11M | $14.5M | |
Change in Accounts Receivable | $537K | -$3.5M | -$3.7M | -$2.4M | -$2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$19.9M | -$25.3M | -$25.6M | -$6.4M | $7.4M | |
Capital Expenditures | $4M | $12.3M | $4.2M | $4.6M | $5.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$4.1M | -$243.7M | $44.2M | -$59.5M | -$55.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.1M | $1.2M | -- | -- | -- | |
Long-Term Debt Repaid | -$309K | -$237K | -$571K | -$483K | -$53K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $387.4M | -$310.4M | -$233.4M | -$358.3M | -$101.1M | |
Cash From Financing | $388.8M | -$309.3M | -$233.6M | -$355.6M | -$101M | |
Beginning Cash (CF) | $390.1M | $1.8B | $1.6B | $2B | $1.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $364.8M | -$578.3M | -$215M | -$421.5M | -$149.2M | |
Ending Cash (CF) | $754.8M | $1.2B | $1.4B | $1.6B | $1.5B | |
Levered Free Cash Flow | -$23.9M | -$37.6M | -$29.8M | -$10.9M | $2.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$154.8M | -$92.1M | -$32.3M | $1.8M | |
Depreciation & Amoritzation | -- | $31.4M | $33.7M | $36.6M | $35.6M | |
Stock-Based Compensation | $847K | $27.4M | $34M | $42.9M | $50.8M | |
Change in Accounts Receivable | -- | -$8.8M | -$10.5M | -$7M | -$5.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$74M | -$29M | $27.7M | $85.7M | |
Capital Expenditures | $4M | $26.6M | $19.7M | $18.7M | $20.1M | |
Cash Acquisitions | -- | -$47.4M | -- | -- | -- | |
Cash From Investing | -- | -$323.7M | $147.5M | -$51.8M | -$7.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $3.5M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$2.1M | -$112.4M | -$6.9M | -$68M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $406.9M | $116.9M | $169.1M | -$72.8M | |
Cash From Financing | -- | $869.8M | $74M | $168.8M | -$185.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $472.1M | $192.5M | $144.8M | -$107.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$100.7M | -$48.7M | $9.1M | $65.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$70M | -$25.1M | -$16M | -$1M | -$7.3M | |
Depreciation & Amoritzation | $7.1M | $7.7M | $8.6M | $9.3M | $8.7M | |
Stock-Based Compensation | $847K | $6.8M | $8.9M | $11M | $14.5M | |
Change in Accounts Receivable | $537K | -$3.5M | -$3.7M | -$2.4M | -$2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$19.9M | -$25.3M | -$25.6M | -$6.4M | $7.4M | |
Capital Expenditures | $4M | $12.3M | $4.2M | $4.6M | $5.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$4.1M | -$243.7M | $44.2M | -$59.5M | -$55.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.1M | $1.2M | -- | -- | -- | |
Long-Term Debt Repaid | -$309K | -$237K | -$571K | -$483K | -$53K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $387.4M | -$310.4M | -$233.4M | -$358.3M | -$101.1M | |
Cash From Financing | $388.8M | -$309.3M | -$233.6M | -$355.6M | -$101M | |
Beginning Cash (CF) | $390.1M | $1.8B | $1.6B | $2B | $1.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $364.8M | -$578.3M | -$215M | -$421.5M | -$149.2M | |
Ending Cash (CF) | $754.8M | $1.2B | $1.4B | $1.6B | $1.5B | |
Levered Free Cash Flow | -$23.9M | -$37.6M | -$29.8M | -$10.9M | $2.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.